Public Health
Volume 122, Issue 1 , Pages 11-18 , January 2008

Prevalence, awareness, treatment and control of hypertension in Malaysia: A national study of 16,440 subjects

  • L. Rampal

      Affiliations

    • Faculty of Medicine and Health Science, Universiti Putra Malaysia Serdang, Selangor, Malaysia
    • Corresponding Author InformationCorresponding author.
    • ,
  • S. Rampal

      Affiliations

    • Faculty of Medicine, University of Malaya, Malaysia
    • ,
  • M.Z. Azhar

      Affiliations

    • Faculty of Medicine and Health Science, Universiti Putra, Malaysia
    • ,
  • A.R. Rahman

      Affiliations

    • Cyberjaya University College of Medical Sciences, Cyberjaya, Malaysia

Received 6 November 2006 ,Revised 22 March 2007 ,Accepted 15 May 2007.

References 

  1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349:1269–1276
  2. World Health Organization. World health report. Mental health: new understanding, new hope. Geneva: WHO; 2001;p. 144–9
  3. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–2369
  4. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am. 1997;81:1077–1097
  5. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101–106
  6. Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–1360
  7. Whitworth JA. 2003 World Health Organization/International Society of Hypertension statement on management of hypertension: WHO, ISH Writing Group. J Hypertens. 2003;21:1983–1992
  8. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
  9. World Health Organization. World health report 2002 Reducing risks, promoting healthy life. Geneva: WHO; 2002;
  10. Ueshima H, Zhang H, Choudhury SR. Epidemiology of hypertension in China and Japan. J Hum Hypertens. 2000;14:765–769
  11. Singh RB, Suh IL, Singh VP, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000;14:749–763
  12. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA. 1996;275:1571–1576
  13. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562
  14. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13–18
  15. MacMahon S, Peto R, Cutler J, Collins R, Sorlie E, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774
  16. StataCorp. Stata statistical software: release 9.2. Texas: Stata Corporation; 2005;
  17. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003;1206–52.
  18. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for the health professionals. Circulation. 1991;83:356–362
  19. Rampal L, Sanjay R, Azhar MZ, Shafie O, Ramlee R, Sirajoon NAG, et al. A population based national study on the prevalence of smoking among Malaysians aged 15 years and above. In:  Varma AK editors. Tobacco counters health. vol. 4:New Delhi: Northern Book Centre; 2006;p. 113–121
  20. Ministry of Health, Malaysia. Report of the second national health and morbidity survey conference proceedings. 1997. p. 71–80.
  21. Burt VL, Curtler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Hypertension. 1995;26:60–69
  22. Ashraf MS, Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Res. 2006;8:368–376
  23. Rasool AHG, Rahman ARA, Ismail R, Hatim S, Abdullah ARW, Singh R, et al. Ethnic differences in response to non-selective beta blockade among racial groups in Malaysia. Int J Clin Pharmacol Ther 2000;260–9.
  24. Rehman AR, Rasool AHG, Rahman AR. Influence of angiotensin 11 type 1 receptor gene A1166C polymorphism on BP and aortic pulse wave velocity among Malays. Ann Hum Genet. 2007;71:86–95
  25. Wang Z, Wu Y, Zhao L, Yang J, Zhou B. Cooperative research group of the study on trends of cardiovascular diseases in China and preventive strategy for the 21st century. Hypertens Res. 2004;27:703–709
  26. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413–46.
  27. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;15:217–223
  28. Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens. 2004;26:731–738

PII: S0033-3506(07)00170-9

doi: 10.1016/j.puhe.2007.05.008

Public Health
Volume 122, Issue 1 , Pages 11-18 , January 2008

Article Tools